RULE 15 WAIVER AND REDEMPTION AGREEMENT relating to OSIRIUM TECHNOLOGIES PLC as Company between OCTOPUS AIM VCT PLC as Noteholder 1 OCTOPUS AIM VCT 2 PLC as Noteholder 2 SAILPOINT TECHNOLOGIES UK LTD as OfferorWaiver and Redemption Agreement • August 29th, 2023
WAIVER AND REDEMPTION AGREEMENTWaiver and Redemption Agreement • December 20th, 2024 • Fennec Pharmaceuticals Inc. • Biological products, (no disgnostic substances)
This Waiver and Redemption Agreement, dated as of December 18, 2024 (this “Agreement”), is entered into by and among Fennec Pharmaceuticals, Inc., a British Columbia corporation (the “Company”), the investors party hereto (the “Investors”), and Petrichor Opportunities Fund I LP, as collateral agent (in such capacity, the “Collateral Agent”; and together with the Company and the Investors, collectively, the “Parties”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed thereto in the Securities Purchase Agreement.
